Teewinot Life Science

Teewinot Life Science

Pharmaceutical company that manufactures and licenses technology to make cannabinoid based therapies.

Teewinot Life Sciences is a privately held biopharmaceutical company based in Tampa, Florida. The company focuses on the biosynthetic production of pure pharmaceutical grade cannabinoids through its patented production process known as CannSynthesis. By combining synthetic biology, biocatalysis, chemical synthesis, bioinformatics, and metabolomics, the cannabinoids produced by Teewinot have the identical chemical structure of cannabinoids found in the Cannabis plant.

Teewinot's technology is also used to custom manufacture pharmaceutical drugs, new biological products including neutraceuticals, cosmeceuticals, and medical veterinary product for other research and development organizations. In addition, it manufactures and licenses technology to make cost-effective and pharmaceutically pure cannabinoids.

In October 2018, the company announced the launch of a new subsidiary, Canalis Pharmaceuticals, a drug discovery and development company that uses cannabinoids and their NCEs (New Chemical Entities) as small molecule libraries for identifying compounds with human therapeutic activity.

Timeline

May 2017

Teewinot Life Science raises a $12,300,000 series B round from Tuatara Capital.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Bryan Brink

CFO

Charles Brink

President, Chairman, & CEO

Dr. Malcolm Kavarana

Chief Scientific Officer & Senior Director, Intellectual Property.

Eric A. Walker

Chief Information Officer

Further reading

Title
Author
Link
Type
Date

Teewinot Life Sciences Corporation's Subsidiary, Teewinot Technologies, Ltd. Announced Today: Grant of a New Patent with Broad Claims to Biosynthetic Production of Cannabinoid Pharmaceuticals | Markets Insider

finanzen.net GmbH

Web

Teewinot Life Sciences' Patented Biosynthetic Tech Cuts Costs and Produces Clinical-Grade Cannabinoids - CannabisNewsWire

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.